We don't know what is attributable to DT because we are not...

We don't know what is attributable to DT because we are not privy to Board discussions. DT has indicated he did not have full support on advancing RC220 and the cardio protection program from the outset where he saw great shareholder value. Others have speculated that at least one board member was possibly interest in a fast and lower valuation than the cardio protection market research valuation. I was not at the AGM where this conversation took place, but one HC handle has definitely highlighted their recollection. It seems there was friction from competing interests at board level. Hopefully this is now resolved. It was always a possibility that DT would protect his SH interests if he saw a problem. This hopefully aligns with all shareholders who want to see maximum shareholder value. Unfortunately we did lose some time but if the blocks are gone progress should be as swift as reasonable.